leadf
logo-loader
viewMotive Television Plc

Motive Television gets Apple sign-off for Freeview app

"The company continues to deliver on its product suite,” said Leonard Fertig, chief executive officer of Motive.

TabletKids.jpg
No internet access? No problem with the TabletTV.

Motive Television (LON:MTV) has made its TabletTV product available on the new Apple TV platform in the United States.

The company, which specialises in providing auxiliary services to broadcasters and pay television operators, has received approval from consumer gadgets leviathan Apple for its UK app and has released TabletTV Freeview for sale on use on the Apple TV platform.

TabletTV Freeview for Apple TV in the UK will enable users who have TabletTV portable or mains tuner antennas to use their TabletTV tuners to watch all available Freeview channels on their main televisions via Apple TV. Most Freeview channels are not otherwise available on the Apple TV platform, Motive pointed out.

The app will be available free of charge to users of TabletTV Freeview, but new users will need to buy a TabletTV tuner to use the service.

"The company continues to deliver on its product suite,” said Leonard Fertig, chief executive officer of Motive.

“TabletTV Freeview joins the unique family of TabletTV Plus and TabletTV Internet to provide added viewing choices on iPads, main TVs, and iPhones in the US and UK. Motive plans to continue adding to these capabilities and extending the product line to Android devices in the future," Fertig revealed.

Quick facts: Motive Television Plc

Price: - -

AIM:MTV
Market: AIM
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE gets an injection of optimism from US Remdesivir approval

FTSE 100 got a lift as a first treatment for COVID-19, remdesivir, was approved in the US. London’s leading index added 41 points to 5,826 in early dealings. Gilead Inc (NASDAQ:GILD) produces remdesivir and it is said to cut COVID-19 recovery times by five days. According to the World Health...

9 minutes ago

2 min read